Acro Biotech
Acro Biotech is a privately held, Montclair, California-based manufacturer of rapid diagnostic tests and supporting analyzers, serving clinical, point-of-care, and veterinary customers across women's health, infectious disease, cardiac, oncology, and substance abuse verticals via direct sales globally.
- Company typePrivate
- Founded2005
- HeadquartersRancho Cucamonga, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Acro Biotech does
Acro Biotech, Inc. is a privately held diagnostic manufacturer founded in 2005 and headquartered at 4650 Arrow Highway, Suite D6, Montclair, California. The company designs, manufactures, and sells rapid diagnostic tests across eight vertical categories — COVID-19 respiratory infection, women's health, infectious disease, drugs of abuse, tumor markers, cardiac markers, veterinary, and other products — alongside a portfolio of supporting instruments including the ACO300 urine analyzer, AFR-600 fluorescence immunoassay analyzer, LF Reader lateral flow reader, and AHR-100 multi-parameter hemoglobin/cholesterol/uric acid/glucose meter. The underlying technology stack is rooted in lateral flow immunoassay chemistry, fluorescence-based quantitative immunoassay, and automated urine/blood analysis for point-of-care clinical use.
The company serves hospitals, clinics, laboratories, and other clinical and point-of-care healthcare settings via a direct sales model with a claimed global reach, supported by a North America operational footprint. The customer base spans seven distinct use-case segments: clinical healthcare providers, women's health testing, infectious disease testing, drugs of abuse screening, tumor marker screening, cardiac assessment, and veterinary diagnostics. Marketing is conducted primarily through the company's website and social channels (Facebook, LinkedIn, YouTube). Acro Biotech's COVID-19 tests are explicitly not authorized, cleared, or approved by the US FDA and are not distributed in the United States, which materially restricts US market access for that product line. The company is small (51–100 employees), operates without a parent company or disclosed institutional investors, and has no disclosed funding rounds, leadership changes, or M&A activity in the source data.
Acro Biotech firmographics
Firmographics- Name
- Acro Biotech
- Legal name
- Acro Biotech, Inc.
- Website
- https://acrobiotech.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Acro Biotech is a privately held, Montclair, California-based manufacturer of rapid diagnostic tests and supporting analyzers, serving clinical, point-of-care, and veterinary customers across women's health, infectious disease, cardiac, oncology, and substance abuse verticals via direct sales globally.
- Ownership category
- akta.pro rank
Acro Biotech industry classification
Industry- Product category
- In-Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)
- akta.pro secondary industries
- Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy) (HLAMAFAI), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
Keywords
Where Acro Biotech is headquartered
LocationHeadquarters
- HQ city
- Rancho Cucamonga
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Acro Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels3 records
Acro Biotech product offering
Product offeringCore offering
Acro Biotech manufactures and sells rapid diagnostic test kits across multiple clinical categories, including COVID-19, infectious disease, women's health, cardiac markers, tumor markers, drugs of abuse, and veterinary applications. It also designs and sells supporting diagnostic instruments such as urine analyzers, a fluorescence immunoassay analyzer, a lateral flow reader, and a multi-parameter Hb/cholesterol/uric acid/glucose meter, intended for clinical, point-of-care, and home use.
Product overview
Acro Biotech is a manufacturer of rapid diagnostic tests and medical instruments. The product portfolio includes multiple categories of rapid test kits (COVID-19, Women's Health, Infectious Disease, Drugs of Abuse, Tumor Markers, Cardiac Markers, Others, and Veterinary) alongside supporting diagnostic instruments including the ACO300 Urine Analyzer, AFR-600 Fluorescence Immunoassay Analyzer, LF Reader, and AHR-100 multi-parameter meter. The company operates from Montclair, California and serves the United States market with these diagnostic products.
Differentiator
Problem solved
Functional benefit
Products and services
- COVID-19 Tests
Companies that use Acro Biotech
Customer profileSegments7 records
Ideal customer profiles2 records
Acro Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Acro Biotech partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights4 records
Acro Biotech competitors and assessment
Company assessmentBroad incumbents
- QuidelOrtho: Major U.S. diagnostics incumbent offering a broad portfolio of rapid immunoassays, lateral flow tests, and immunoassay analyzers spanning infectious disease, women's health, and cardiac markers — directly overlapping Acro Biotech's product categories but at significantly larger scale.
- Abbott Rapid Diagnostics: Global leader in rapid diagnostics (Binax, Panbio, Determine) covering infectious disease, cardiac, drugs of abuse, and women's health — competes head-to-head with Acro Biotech across nearly every product category.
- Becton Dickinson (BD): Diversified medical technology company with a large diagnostics segment including rapid immunoassays, point-of-care analyzers, and clinical chemistry instruments — overlapping with Acro Biotech's instruments and rapid test kits.
- Hologic: Major women's health diagnostics company (Aptima, ThinPrep, Rapid fFN) with overlapping women's health and infectious disease testing portfolios — an established incumbent in several of Acro Biotech's target segments.
Direct peers
- Wondfo Biotech: China-based manufacturer of rapid diagnostic test kits covering infectious disease, drugs of abuse, cardiac markers, and women's health — a closely comparable mid-sized lateral flow test manufacturer competing with Acro Biotech in international markets.
- Hangzhou AllTest Biotech: Specialized rapid diagnostic test manufacturer producing lateral flow assays across infectious disease, fertility, drugs of abuse, and cardiac markers — a close head-to-head peer in product mix and OEM/private-label positioning.
- CTK Biotech: San Diego-based developer and manufacturer of rapid diagnostic tests for infectious diseases, women's health, drugs of abuse, and tumor markers — directly comparable in geography, scale, and product portfolio to Acro Biotech.
- Chembio Diagnostics: Small-cap rapid diagnostic manufacturer focused on point-of-care infectious disease and immunoassay tests — comparable in size and lateral flow focus, with similar commercial dynamics facing larger incumbents.
- Princeton BioMeditech: Manufacturer of rapid diagnostic tests and immunoassay analyzers for drugs of abuse, pregnancy, and infectious disease — closely mirrors Acro Biotech's combination of kits and benchtop analyzers.
- Bioteke Corporation: Manufacturer of rapid diagnostic test kits including infectious disease, cardiac, fertility, and drugs of abuse panels, with both lateral flow and analyzer offerings — closely comparable in product breadth and international distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Acro Biotech social profiles
Digital presenceAcro Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Acro Biotech leadership team
Management profileNumber of profiles
Acro Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Acro Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Acro Biotech
What does Acro Biotech do?
Acro Biotech manufactures and sells rapid diagnostic test kits across multiple clinical categories, including COVID-19, infectious disease, women's health, cardiac markers, tumor markers, drugs of abuse, and veterinary applications. It also designs and sells supporting diagnostic instruments such as urine analyzers, a fluorescence immunoassay analyzer, a lateral flow reader, and a multi-parameter Hb/cholesterol/uric acid/glucose meter, intended for clinical, point-of-care, and home use.
Is Acro Biotech a public or private company?
Acro Biotech is a private company. It is classified as unknown and is currently operating.
When was Acro Biotech founded?
Acro Biotech was founded in 2005. It employs 51 to 100 people.
Where is Acro Biotech based?
Acro Biotech is headquartered in Rancho Cucamonga, United States, in the North America region.
Who are Acro Biotech's main competitors?
Broad incumbents on record are QuidelOrtho, Abbott Rapid Diagnostics, Becton Dickinson (BD) and Hologic. Direct peers are Wondfo Biotech, Hangzhou AllTest Biotech, CTK Biotech, Chembio Diagnostics, Princeton BioMeditech and Bioteke Corporation.
Does Acro Biotech have an API?
No public API is recorded for Acro Biotech.
What industry is Acro Biotech in?
Acro Biotech's product category is In-Vitro Diagnostics. Its primary akta.pro industry code is HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 325413 and its SIC code is 2835.